Product information and disease descriptionProduct descriptionProduct informationDosing and administration
Dosage
1 evidence topic · 2 sources
Bezuclastinib
Gastrointestinal stromal tumor
- Manufacturer
- Cogent Biosciences
- Regulatory submission
- NDA submitted April 2026
- Last updated